Literature DB >> 28107592

Psoriasis and palmoplantar pustulosis: an endless debate?

A M G Brunasso1, C Massone1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28107592     DOI： 10.1111/jdv.14131

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea.

Authors:  Dong Hyo Kim; Jin Yong Lee; Soo Ick Cho; Seong Jin Jo
Journal:  JAMA Dermatol       Date:  2022-06-01       Impact factor: 11.816

Review 2.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

3.  Efficacy of guselkumab in a subpopulation with pustulotic arthro-osteitis through week 52: an exploratory analysis of a phase 3, randomized, double-blind, placebo-controlled study in Japanese patients with palmoplantar pustulosis.

Authors:  T Yamamoto; K Fukuda; A Morita; T Kimura; H Morishima; R Goto; R Zheng; T Terui
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-15       Impact factor: 6.166
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.